Clinical Trials on Tricuspid Valve Disease in United States

Total 147796 results

Barts & The London NHS Trust
University College, London

Not yet recruiting

Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure) (Measure)

Aortic Valve Disease | Surgery--Complications | Immune System Disorder

United Kingdom
Baylor College of Medicine
Edwards Lifesciences

Recruiting

Outcomes of Pulmonary Valve Replacement With the INSPIRIS (Model 11500A) Valve

Heart Valve Prosthesis

United States
University of Edinburgh

Unknown

Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis (PASS)

Aortic Stenosis | Transthyretin Amyloidosis

United Kingdom
Abbott Medical Devices

Active, not recruiting

Portico NG Approval Study

Symptomatic Severe Aortic Stenosis

United States, Australia, Denmark, Italy, United Kingdom
Metanoic Health Ltd.
Abbott Medical Devices

Completed

Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients (MRAHF)

Mitral Regurgitation | Acute Heart Failure

United Kingdom
Joshua Kanter

Active, not recruiting

Radiation-Free Heart Catheterization Using MRI

Aortic Stenosis | Atrial Septal Defect | Aortic Coarctation | Patent Ductus Arteriosus | Cardiomyopathy | Post Heart Transplant Catheter Procedure

United States
Indiana University
American Heart Association

Recruiting

Pediatric Cardiomyopathy Mutation Analysis

Cardiomyopathies | Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Arrhythmogenic Right Ventricular Cardiomyopathy | Restrictive Cardiomyopathy | Left Ventricular Non-compaction Cardiomyopathy

United States
Edwards Lifesciences

Completed

Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study (SAPIEN3)

Aortic Valve Disease

United Kingdom, France, Germany, Italy, Canada
University of Edinburgh

Completed

Mechanism of Decompensation Evaluation - Aortic Stenosis (MODE-AS)

Myocardial Fibrosis | Aortic Stenosis | Left Ventricular Hypertrophy

United Kingdom
Institut für Pharmakologie und Präventive Medizin
Edwards Lifesciences

Completed

Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI (TASQ)

Aortic Valve Stenosis

Austria, Canada, France, Germany, Italy, Spain, United Kingdom
Edwards Lifesciences

Terminated

Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device. (ASCEND)

Mitral Regurgitation

Germany, Netherlands, Austria, United Kingdom
Edwards Lifesciences

Completed

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk (PII A)

Symptomatic Severe Aortic Stenosis

United States, Canada
Imperial College London
British Heart Foundation; Humboldt-Universität zu Berlin

Completed

Identifying an Ideal Cardiopulmonary Exercise Test Parameter (PVA)

Mitral Regurgitation | Left Ventricular Systolic Dysfunction

United Kingdom
Seattle Children's Hospital

Terminated

Intraarticular Corticosteroid Therapy in Perthes Disease.

Legg-Calve Perthes Disease

United States
Edwards Lifesciences
American College of Cardiology

Completed

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B (PARTNERII B)

Calcific Aortic Stenosis | Severe | Symptomatic

United States
University Medical Center Goettingen
University Medical Center Goettingen

Completed

A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation (Reshape-HF2)

Mitral Valve Insufficiency

United Kingdom, Germany, Spain, Denmark, Poland, Greece, Portugal, Czechia, Italy
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (MERCUTIO)

Cardiomyopathy, Hypertrophic

United States, Poland, Spain, Italy
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cardiomyopathy, Hypertrophic

United States, Australia, Canada, France, Germany, Ireland, Italy, Spain, United Kingdom
Cytokinetics

Completed

Dose-finding Study to Evaluate the Safety, Tolerability, PK, and PD of CK-3773274 in Adults With HCM (REDWOOD-HCM)

Hypertrophic Cardiomyopathy (HCM)

United States, Spain, Italy, Netherlands
Ottawa Heart Institute Research Corporation

Recruiting

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock (MINOS)

Mitral Regurgitation | Cardiogenic Shock

United States, Canada
University of California, San Francisco

Completed

Tetralogy of Fallot Seed Grant

Pulmonary Regurgitation After Repair of Tetralogy of Fallot

United States
Washington University School of Medicine
University of Pittsburgh; American Glaucoma Society

Recruiting

Tied Tube Trial in Glaucoma Surgery

Glaucoma Eye | Ahmed Glaucoma Valve Implantation

United States
Tulane University

Completed

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

Cardiomyopathies | Valvular Heart Disease | Pericardial Disease

United States
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy (VALOR-HCM)

HOCM, Hypertrophic Obstructive Cardiomyopathy

United States
Medical University of Vienna
Medical University of South Carolina; IRCCS Azienda Ospedaliero-Universitaria... and other collaborators

Recruiting

Aortic Stenosis and Cardiac Amyloidosis

Aortic Stenosis | Cardiac Amyloidosis

Austria, United Kingdom
Medtronic Bakken Research Center

Completed

CoreValve Advance International Post Market Study

Severe Aortic Stenosis

Italy, Israel, Germany, Netherlands, Greece, France, Switzerland, United Kingdom, Portugal, Denmark, Belgium, Colombia
University of Edinburgh
NHS Lothian; British Heart Foundation

Completed

Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. (SALTIRE II)

Calcific Aortic Stenosis

United Kingdom
Abbott Medical Devices

Completed

FlexNav EU CE Mark Study

Symptomatic Severe Aortic Stenosis

Denmark, Switzerland, United Kingdom, Italy
Abbott Medical Devices

Recruiting

Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation (VANTAGE)

Symptomatic Severe Aortic Stenosis

Spain, Denmark, United Kingdom, France, Italy, Australia, Germany, Netherlands, Switzerland, Austria
Medtronic Cardiovascular

Active, not recruiting

Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

Severe Aortic Stenosis

United States
Medtronic Cardiovascular

Completed

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

Severe Aortic Stenosis

United States
Cedars-Sinai Medical Center

Recruiting

Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation (RESOLVE)

Prosthetic Valve Thrombosis

United States
LMU Klinikum

Recruiting

Tendyne European Experience Registry (TENDER)

Mitral Regurgitation

Switzerland, Belgium, France, Germany, Spain, Austria, Italy, Norway, Sweden, United Kingdom
Medtronic Cardiovascular

Recruiting

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial (APOLLO-EU)

Mitral Regurgitation

Spain, Denmark, France, United Kingdom, Germany, Netherlands, Switzerland
Edwards Lifesciences

Completed

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve (PII NR3/ViV)

Aortic Stenosis | Cardiomyopathy, Hypertrophic

United States, Canada
Heart Metabolics Limited

Terminated

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

Cardiomyopathy, Hypertrophic | Cardiomyopathy, Hypertrophic, Familial

United States
HighLife SAS
ICON plc

Recruiting

Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe Mitral Regurgitation and at High Surgical Risk

Mitral Regurgitation

Belgium, France, Germany, Australia, United Kingdom, Poland
Barts & The London NHS Trust
Queen Mary University of London; Boston Scientific Corporation

Recruiting

Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous) (HICD)

Implantable Defibrillator User | Hypertrophic Cardiomyopathy | Ventricular Arrythmia | Implantable Cardioverter Ventricular Lead Dysfunction or Complication

United Kingdom
Abbott Medical Devices

Completed

Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve

Heart Valve Diseases

United States
Optimapharm
Edwards Lifesciences

Active, not recruiting

RHEIA (Randomized researcH in womEn All Comers With Aortic Stenosis) (RHEIA)

Aortic Valve Stenosis | Heart Valve Diseases

United Kingdom, Italy, Germany, France, Austria, Switzerland, Finland, Czechia, Belgium, Netherlands, Cyprus, Ireland
Aristotle University Of Thessaloniki
Clinical Research Unit, School of Medicine, Aristotle University of Thessaloniki

Recruiting

MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) (MiECS)

Coronary Artery Disease | Aortic Valve Stenosis | Extracorporeal Circulation; Complications

Canada, Germany, Greece, Italy, Switzerland, Turkey, United Kingdom
Edwards Lifesciences

Active, not recruiting

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis (P3)

Aortic Stenosis

United States, Australia, Japan, Canada, New Zealand
Abbott Medical Devices

Completed

Portico TAVI Implant With Transfemoral Delivery System

Symptomatic Aortic Stenosis

United Kingdom, Germany, Netherlands, Denmark, Australia
Edwards Lifesciences

Active, not recruiting

SAPIEN 3 Ultra EU PMS

Aortic Stenosis | Aortic Valve Stenosis

Portugal, Spain, Switzerland, Italy, United Kingdom, Finland, France, Germany, Austria, Norway
MyoKardia, Inc.

Completed

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) (MAVERICK-HCM)

Non-obstructive Hypertrophic Cardiomyopathy

United States
Queen Silvia Children's Hospital, Gothenburg, Sweden
Sahlgrenska University Hospital, Sweden; Swedish Heart Lung Foundation

Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes (FASSprosp)

Aortic Valve Stenosis | Congenital Heart Disease | Hypoplastic Left Heart Syndrome | Fetal Cardiac Disorder

United States, Austria, Canada, Finland, Germany, Poland, Spain, Sweden
Edwards Lifesciences

Completed

SOURCE XT REGISTRY

Severe Aortic Stenosis

Spain, Italy, Canada, Belgium, Greece, Germany, Austria, United Kingdom, Finland, Denmark, France, Switzerland, Israel, Poland, South Africa, Czechia, Netherlands, Norway
Imperial College London

Recruiting

The SMARTER Cardiomyopathy Study (SMARTER-CM)

Cardiomyopathies | Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy

United Kingdom
Edwards Lifesciences
University of British Columbia; Medstar Health Research Institute; European Cardiovascular...

Completed

CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve

Aortic Valve Disease

Australia, Denmark, Germany, Switzerland, France, New Zealand, Italy, United Kingdom, Netherlands
Montefiore Medical Center

Recruiting

The Bronx-Valve Registry

Valvular Heart Disease

United States

Clinical Trials on Tricuspid Valve Disease in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations